Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01753921 · ClinicalTrials.gov registry record

Evaluation of a Non-invasive Brain Compliance Measurement Device

A clinical trial of Diabetes and Diabetic Ketoacidosis, sponsored by Stanford University.

Completed
Registry status
14
Enrollment target
1
Study location

NCT01753921 is a study of Diabetes and Diabetic Ketoacidosis that has completed, run by Stanford University. The registered enrollment target is 14 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01753921, a study of Diabetes and Diabetic Ketoacidosis, has completed, sponsored by Stanford University.

COMPLETED
Registry status
14 participants
Enrollment target
1
Study location

Study Summary

This is a research study to understand how diabetic ketoacidosis may affect the brain and learning and to see if these changes are transient or permanent. The investigators hope to learn more about how diabetic ketoacidosis may cause changes in brain compliance (by wearing a non-invasive head band/helmet like device from Jan Medical: The Nautilus Neurowave System™ (NNS), learning, talking, behavior, or development. The investigators will compare those results from those with diabetes mellitus to those age and gendered matched healthy controls. Possible subjects in this study have diabetes mellitus and are between the ages of 10 to less than 17 years old OR do NOT have diabetes and are between the ages of 10 to less than 17 years old.

Interventions

  • DEVICE MRI
  • OTHER this is not an intervention study

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2011-11
Est. Completion 2016-10

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT01753921

The ClinicalTrials.gov registry entry for NCT01753921 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.

NCT01753921 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01753921 about?

NCT01753921 is a clinical study titled "Evaluation of a Non-invasive Brain Compliance Measurement Device". This is a research study to understand how diabetic ketoacidosis may affect the brain and learning and to see if these changes are transient or permanent. The investigators hope to learn more about how diabetic ketoacidosis may cause changes in brain compliance (by wearing a non-invasive head band/h...

What is the current status of trial NCT01753921?

This trial is currently completed. The enrollment target is 14 participants. The study started on 2011-11. Estimated completion is 2016-10.

What conditions does trial NCT01753921 study?

This clinical trial studies the following conditions: Diabetes, Diabetic Ketoacidosis.

What interventions are being tested in trial NCT01753921?

The interventions under investigation include: MRI (DEVICE), this is not an intervention study (OTHER).

Who is sponsoring clinical trial NCT01753921?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01753921 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.